Funding Supports Innovative Research Leveraging Artificial Intelligence, Advanced Technologies and Novel Therapies to Improve Patient Outcomes DALLAS – Susan G. Komen®, the world’s leading breast cancer organization, today awarded $15.4 million in grants to cutting-edge breast cancer researchers who are bringing us closer to the cures for all breast cancers. The funded projects span some […]

PHOENIX – Susan G. Komen®, the world’s leading breast cancer organization, issued the following statement on the passage of critical breast imaging legislation in Arizona, SB 1165, led by Senator Hildy Angius. Diagnostic and supplemental imaging is a critical form of breast cancer screening for some high-risk individuals and an important step in determining the […]

House Appropriators Advance Funding Bill That Supports Early Detection Programs, Research Benefiting Millions WASHINGTON, DC – Susan G. Komen®, the world’s leading breast cancer organization, commends members of the U.S. House Appropriations Committee for advancing legislation to increase funding for critical breast cancer programs but cautions against the broader trend of decreasing public health funding.  […]

Urges Full House Action So Millions Can Get the Critical Care They Need WASHINGTON, DC – Susan G. Komen®, the world’s leading breast cancer organization, commends members of the U.S. House Energy and Commerce Committee for passing the SCREENS for Cancer Act and the EARLY Act Reauthorization of 2025, an important step in the legislative […]

Breast Cancer Community Urges Action During Annual Advocacy Summit WASHINGTON, DC – Susan G. Komen®, the world’s leading breast cancer organization, urged lawmakers on Capitol Hill to put their full support behind pending legislation that would expand access to early detection and require insurance companies to fully cover the cost of all recommended breast imaging, […]

Annual Events Raise Critical Funds for Lifesaving Research, Advocacy and Direct Patient Support, Driving Local Impact PHILADELPHIA – Susan G. Komen®, the world’s leading breast cancer organization, will bring together breast cancer survivors, those living with metastatic breast cancer (MBC) and supporters at two Pennsylvania MORE THAN PINK Walks in May. Our community will come together to make sure no one faces breast cancer alone and help advance Komen’s […]

Proceeds from Stamp have Funded Nearly $100 Million in Breast Cancer Research WASHINGTON, DC –  Susan G. Komen®, the world’s leading breast cancer organization, applauds the introduction of the Breast Cancer Research Stamp Reauthorization Act of 2026 and urges swift passage to secure continued vital research funds. The legislation, introduced by Senator Jacky Rosen (D-NV), Senator Ashley Moody (R-FL), Representative Beth […]

Warns Research Cuts in President’s Budget Could Cost Lives  Susan G. Komen®, the world’s leading breast cancer organization, opposes the Trump Administration’s plans to cut $5 billion in funding for vital medical research as part of its proposed fiscal year 2027 (FY27) budget. While Komen is pleased to see that the National Breast and Cervical Cancer Early Detection Program (NBCCEDP), the only option for breast and cervical cancer screening for millions of Americans, would be funded at current levels, more funding is needed to serve all who qualify.   “Komen calls […]

BOISE – Susan G. Komen®, the world’s leading breast cancer organization, commends the passage of legislation that will require individual health insurance plans to cover oral, self-administered anticancer medications on terms no less favorable than the coverage for intravenous (IV), injected, or port-administered therapies. HB 648, sponsored by Rep. Chris Bruce (R – Kuna), will […]

Susan G. Komen®, the world’s leading breast cancer organization, issued the following statement on the passage of critical breast imaging legislation in Wisconsin, SB 264 or Gail’s Law. Diagnostic and supplemental imaging are critical forms of breast cancer screening for some high-risk individuals and an important follow-up step in determining the need for a biopsy […]

INDIANAPOLIS, INDIANA – Susan G. Komen®, the world’s leading breast cancer organization, issued the following statement on the passage of HB 1114, which prohibits the use of step therapy protocols for metastatic cancer patients. Step therapy, also referred to as “fail first,” requires a patient to first try a health plan preferred drug, have that […]

Annual Event to Fuel Research Advancements and Strengthen the St. Louis Community with Vital Support Susan G. Komen®, the world’s leading breast cancer organization, will convene breast cancer survivors, those living with metastatic breast cancer (MBC) and supporters at the St. Louis MORE THAN PINK Walk on Saturday, June 6 in a NEW LOCATION – […]